Maharashtra deputy chief minister Eknath Shinde has directed the state health department to include rare diseases under the Mahatma Jyotirao Phule Jan Arogya Yojana (MJPJAY), according to a statement. The move is aimed at ensuring that patients with rare conditions such as Spinal Muscular Atrophy (SMA) get timely diagnosis and effective treatment without their families bearing the financial burden of expensive care.

Shinde also asked the department to prepare a comprehensive standard operating procedure for treating SMA patients and to strengthen early diagnosis, patient registration and treatment processes. The directions followed a Wednesday meeting where the current status of SMA patients in Maharashtra, diagnosis, available treatment options, medicine availability and the challenges patients face were discussed in detail.

The central government has selected KEM Hospital in Mumbai as the Centre of Excellence for the state. The centre handles diagnosis of rare diseases, patient registration and related treatment procedures, but a clearly defined protocol is needed so that patients receive treatment more easily and without delay.

Since SMA treatment facilities are also available at Wadia Children's Hospital in Mumbai, Shinde directed the health department to prepare a proposal and send it to the Union health ministry seeking Centre of Excellence status for the hospital as well. He said he will write personally to the Union health minister and follow up on the matter. He also asked that the disease be brought under MJPJAY so treatment is not delayed due to financial constraints, and that KEM Hospital include the essential medicines for treating the disease in its essential medicines list and procure them accordingly.